Oxytocic Pharmaceuticals Market Report Scope & Overview:

The Oxytocic Pharmaceuticals Market Size was valued at USD 114.57 Million in 2023 and is expected to reach USD 210.49 Million by 2031, and grow at a CAGR of 7.9% over the forecast period 2024-2031.

Oxytocic is a class of medicines used at the end of pregnancy, during labour, and after delivery to cause the smooth musculature of the uterus to contract selectively. Oxytocic medications are used in obstetrics for a variety of purposes, including induction of labor, labour arrest treatment, contraction stress testing, labour management, and the treatment of uterine atony and postpartum hemorrhage.

Oxytocic Pharmaceuticals Market Revenue Analysis

Get more information on Oxytocic Pharmaceuticals Market - Request Sample Report

In case of premature delivery, the drug is likewise used to end the embryo. Following a C-area, oxytocic prescriptions are given to forestall uterine atony. Due to the lack of vasopressin, synthetic oxytocin derivatives might cause antidiuretic effects.

The key reason factors for the growth of the oxytocic pharmaceuticals market is the rising tendency of giving birth in hospitals rather than at home, as well as the rising number of caesarian procedures. Furthermore, the numerous types of goods offered by various companies associated to oxytocic drugs in order to acquire market share are causing competition in the oxytocic pharmaceuticals industry. The essential issues restricting the development of the oxytocic drug industry are the adverse consequences related to oxytocic meds that make unreasonable draining following vaginal birth due to post-pregnancy discharge.



  • postpartum hemorrhage is more common

  • Using labor induction to increase childbirth


  • Alternative drug availability

  • Issues with quality


  • Preterm births are becoming more common.

  • Complications related to pregnancy.


The coronavirus outbreak and subsequent shutdown wreaked havoc on all major sectors of the economy, yet it turned out to be a blessing in disguise for pharmaceutical industry. Notwithstanding the way that a few parts of the drug business were influenced, for example, the inventory network and the import of dynamic therapeutic fixings from China, Covid-19 offered a few chances in the drug area.


By Indication

  • Abortion Induced Incomplete

  • Post-partum Haemorrhage

  • Labour Induction

  • Inevitable Abortion

  • Labour Arrest

By Route of administration

  • Intramuscular Injection

  • Intravenous Infusion/Injection

By Source of Origin

  • Synthetic Oxytocin Derivative

  • Natural Oxytocin

By End-User

  • Hospitals

  • Maternity clinics

Oxytocic Pharmaceuticals Market Segmentation Analysis

Need any customization research on Oxytocic Pharmaceuticals Market - Enquiry Now


Because of the high prevalence of induced labour in the region, North America has had the biggest demand for oxytocic medications. Because of the surge in oxytocin administration in response to the increasing number of elective caesareans, Europe is predicted to become the second-largest market for oxytocic drugs. The industry is also expected to benefit from the rising number of C-sections in Asia Pacific nations like India and China.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America


Some of the major key players are Fresenius Kaci, App Pharmaceuticals LLC, Biofutura, Abbott laboratories, Teva Pharmaceutical Industries, JHP Pharmaceuticals LLC, Baxter Healthcare, Pfizer, Novartis, Ferring & Other Players

Teva Pharmaceutical Industries-Company Financial Analysis

Company Landscape Analysis

Oxytocic Pharmaceuticals Market Report Scope:
Report Attributes Details
Market Size in 2023 US$ 114.57 Million
Market Size by 2031 US$ 210.49 Million
CAGR CAGR of 7.9% From 2024 to 2031
Base Year 2023
Forecast Period 2024-2031
Historical Data 2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Indication (Abortion Induced Incomplete, Post-partum Hemorrhage, Labour Induction, Inevitable Abortion, Labour Arrest)
• By Route of Administration (Intramuscular Injection, Intravenous Infusion/Injection)
• By Source of Origin (Synthetic Oxytocin Derivative, Natural Oxytocin)
• By End-User (Hospitals, Maternity clinics)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Fresenius Kaci, App Pharmaceuticals LLC, Biofutura, Abbott laboratories Teva Pharmaceutical Industries, JHP Pharmaceuticals LLC, Baxter Healthcare, Pfizer, Novartis, Ferring.
DRIVERS • Postpartum hemorrhage is more common
• Using labor induction to increase childbirth
RESTRAINTS • Alternative drug availability
• Issues with quality

Frequently Asked Questions

Ans: The Oxytocic Pharmaceuticals market is expected to grow at a CAGR of 7.9% over the forecast period 2024-2031.

Alternative drug availability and Issues with quality are the restraints of the Oxytocic Pharmaceuticals market.

Ans:- The Oxytocic Pharmaceuticals Market Size was valued at US$ 114.57 Million in 2023.

North America had the biggest demand for oxytocic medications.

Manufacturer and service provider, research institutes, universities, and private libraries, suppliers, and distributors.

Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8. Oxytocic Pharmaceuticals Market Segmentation, by Indication

8.1 Abortion Induced Incomplete

8.2 Post-partum Haemorrhage

8.3 Labour Induction

8.4 Inevitable Abortion

8.5 Labour Arrest

9. Oxytocic Pharmaceuticals Market Segmentation, By Route of administration

9.1 Intramuscular Injection

9.2 Intravenous Infusion/Injection

10. Oxytocic Pharmaceuticals Market Segmentation By Source of Origin

10.1 Synthetic Oxytocin Derivative

10.2 Natural Oxytocin

11 Oxytocic Pharmaceuticals Market Segmentation, By End-User

11.1 Hospitals

11.2 Maternity clinics

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2 Canada

12.2.3 Mexico

12.3   Europe

12.3.1 Germany

12.3.2 UK

12.3.3 France

12.3.4 Italy

12.3.5 Spain

12.3.6 The Netherlands

12.3.7 Rest of Europe

12.4   Asia-Pacific

12.4.1 Japan

12.4.2 South Korea

12.4.3 China

12.4.4 India

12.4.5 Australia

12.4.6 Rest of Asia-Pacific

12.5   The Middle East & Africa

12.5.1 Israel

12.5.2 UAE

12.5.3 South Africa

12.5.4 Rest

12.6   Latin America

12.6.1 Brazil

12.6.2 Argentina

12.6.3 Rest of Latin America

13. Company Profiles

13.1 JHP Pharmaceuticals LLC

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 Fresenius Kaci

13.3 App Pharmaceuticals LLC

13.4 Biofutura

13.5 Abbott laboratories

13.6 Teva Pharmaceutical Industries

13.7 Baxter Healthcare

13.8 Pfizer

13.9 Ferring

13.10 Novartis

14 Competitive Landscape

14.1 Competitive Benchmark

14.2 Market Share Analysis

14.3 Recent Developments

15 Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone